Glibenclamide (HB 419, Daonil) in the clinical practice of diabetes.
D000328:Adult; D000368:Aged; D001645:Biguanides / Q000008:administration & dosage / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D005905:Glyburide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D001645:Biguanides; D001786:Blood Glucose; D013453:Sulfonylurea Compounds; D005905:Glyburide